Retained Earnings (Accumulated Deficit) in USD of BriaCell Therapeutics Corp. from Q2 2021 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
BriaCell Therapeutics Corp. quarterly Retained Earnings (Accumulated Deficit) history and change rate from Q2 2021 to Q2 2025.
  • BriaCell Therapeutics Corp. Retained Earnings (Accumulated Deficit) for the quarter ending 31 Jul 2025 was -$112M, a 30.8% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

BriaCell Therapeutics Corp. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 -$112M -$26.3M -30.8% 31 Jul 2025 10-K 16 Oct 2025
Q1 2025 -$104M -$19.4M -23.1% 30 Apr 2025 10-Q 16 Jun 2025
Q4 2024 -$97.5M -$11.6M -13.5% 31 Jan 2025 10-Q 12 Mar 2025
Q3 2024 -$91.2M -$16.6M -22.2% 31 Oct 2024 10-Q 16 Dec 2024
Q2 2024 -$85.4M -$4.79M -5.94% 31 Jul 2024 10-K 16 Oct 2025
Q1 2024 -$84.2M -$6M -7.66% 30 Apr 2024 10-Q 14 Jun 2024
Q4 2023 -$85.9M -$12.6M -17.2% 31 Jan 2024 10-Q 18 Mar 2024
Q3 2023 -$74.7M -$13.2M -21.5% 31 Oct 2023 10-Q 14 Dec 2023
Q2 2023 -$80.7M -$20.3M -33.6% 31 Jul 2023 10-K 29 Oct 2024
Q1 2023 -$78.2M 30 Apr 2023 10-Q 14 Jun 2023
Q4 2022 -$73.3M 31 Jan 2023 10-Q 16 Mar 2023
Q3 2022 -$61.5M 31 Oct 2022 10-Q 14 Dec 2022
Q2 2022 -$60.3M -$31.2M -107% 31 Jul 2022 10-K 25 Oct 2023
Q2 2021 -$29.1M 31 Jul 2021 10-K 28 Oct 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.